{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:09:31Z","timestamp":1773101371062,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Warszawski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["FW24\/NM1\/17"],"award-info":[{"award-number":["FW24\/NM1\/17"]}],"id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/01\/X\/ST5\/00360"],"award-info":[{"award-number":["2017\/01\/X\/ST5\/00360"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bmc.2017.12.016","type":"journal-article","created":{"date-parts":[[2017,12,9]],"date-time":"2017-12-09T18:57:46Z","timestamp":1512845866000},"page":"527-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives"],"prefix":"10.1016","volume":"26","author":[{"given":"Kinga","family":"Ostrowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid","family":"Grzeszczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"G\u0142uch-Lutwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grybo\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Le\u015bniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6309-5292","authenticated-orcid":false,"given":"Mariusz","family":"Sacharczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Trzaskowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2017.12.016_b0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/0929867013372599","article-title":"Serotonin receptor and transporter ligands \u2013 Current status","volume":"8","author":"Oh","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2017.12.016_b0010","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1021\/jm800176x","article-title":"Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands","volume":"51","author":"Siracusa","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.016_b0015","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/ml4004843","article-title":"Enhancing a CH-\u03c0 interaction to increase the affinity for 5-HT1A receptors","volume":"5","author":"Liegeois","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.016_b0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejmech.2017.05.047","article-title":"Synthesis of a new series of aryl\/heteroarylpiperazinyl derivatives of 8-acetyl-7-hydroxy-4-methylcoumarin with low nanomolar 5-HT1A affinities","volume":"137","author":"Ostrowska","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.016_b0025","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1039\/C7MD00281E","article-title":"Development of selective agents targeting serotonin 5-HT1A receptor with subnanomolar activities based on a coumarin core","volume":"8","author":"Ostrowska","year":"2017","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmc.2017.12.016_b0030","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00706-016-1725-7","article-title":"Synthesis and biological screening of a new series of 5-[4-(4-aryl-1-piperazinyl)butoxy]coumarins","volume":"147","author":"Ostrowska","year":"2016","journal-title":"Monatsh Chem"},{"key":"10.1016\/j.bmc.2017.12.016_b0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2017.12.016_b0040","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmc.2017.12.016_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bmc.2017.12.016_b0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0166-2236(96)10037-0","article-title":"Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bmc.2017.12.016_b0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bjp.0701420","article-title":"The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain","volume":"122","author":"Casanovas","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2017.12.016_b0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/jpn.0427","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.bmc.2017.12.016_b0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","article-title":"Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders","volume":"28","author":"Marek","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bmc.2017.12.016_b0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0361-9230(01)00623-2","article-title":"Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists","volume":"56","author":"Gray","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bmc.2017.12.016_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1527-3458.2002.tb00219.x","article-title":"Pharmacology of flibanserin","volume":"8","author":"Borsini","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.bmc.2017.12.016_b0080","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ejmech.2011.03.006","article-title":"Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin","volume":"46","author":"Trykowska Konc","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.016_b0085","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1021\/jm400408r","article-title":"Synthesis and biological investigation of coumarin piperazine (Piperidine) derivatives as potential multireceptor atypical antipsychotics","volume":"56","author":"Chen","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.016_b0090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0969-8051(00)00107-4","article-title":"Central 5-HT1A receptors: regional distribution and functional characteristics","volume":"27","author":"Lanfumey","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmc.2017.12.016_b0095","first-page":"589","article-title":"Pretreatment with the 5-HT1A receptor agonists 8-OH-DPAT or gepirone does not attenuate the inhibitory effect of systemically administered cholecystokinin (CCK) on food intake in rats","volume":"16","author":"Ebenezer","year":"1994","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.bmc.2017.12.016_b0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF02247129","article-title":"Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats","volume":"102","author":"Evenden","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bmc.2017.12.016_b0105","first-page":"1","article-title":"Chronic administration of 5-HT1A receptor agonist relieves depression and depression-induced hypoalgesia","volume":"405736","author":"Jiang","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.bmc.2017.12.016_b0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-002-1121-3","article-title":"Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat","volume":"163","author":"Mignon","year":"2002","journal-title":"Psychopharmacology"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808961732134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808961732134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:53:20Z","timestamp":1760835200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808961732134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S096808961732134X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2017.12.016","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2017.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}